Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

MyoKardia

Request full access

Develops novel, small molecule therapeutics that address key clinical needs of patients with genetic heart diseases

San Francisco, United StatesFounded 2012Biotech & Life Sciences

At a glance

Status
Listed
Listing
IPO 2015

MyoKardia in the San Francisco ecosystem

Live from Dealroom

The MyoKardia office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

Series B and later4 investors entered at this stage

  • University of Colorado Boulder
  • Stanford University
  • Harvard University
  • Harvard Medical School
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 8 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$44M

31 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See MyoKardia on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.